Gleostine® (lomustine)
Home / Our Products / Gleostine® (lomustine)
| NDC | Product Description | Strength | Size | Product Image | Container Type |
|---|---|---|---|---|---|
|
58181-3040-05 |
Gleostine® (lomustine) capsules |
10mg |
5 Capsules |
|
Plastic Bottle |
|
58181-3041-05 |
Gleostine® (lomustine) capsules |
40mg |
5 Capsules |
|
Plastic Bottle |
|
58181-3042-05 |
Gleostine® (lomustine) capsules |
100mg |
5 Capsules |
|
Plastic Bottle |
Gleostine® (lomustine) Capsules
Gleostine® is an oral chemotherapy medication that is used to treat Primary and Metastatic Brain Cancer and Hodgkin’s lymphoma.
product information :
Gleostine® is available in 10mg, 40mg, and 100mg strength capsules with 5 capsules per bottle.
more information :
Gleostine is currently available from NextSource Pharma’s authorized human health and animal health distributors.
For more information about Gleostine® (lomustine), how it works, treatment and our patient assistance program, visit Gleostine.
Warnings:
Gleostine® (lomustine) should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents.
Bone marrow suppression, notably thrombocytopenia and leukopenia, which may contribute to bleeding and overwhelming infections in an already compromised patient, is the most common and severe of the toxic effects of Gleostine® (see WARNINGS and ADVERSE REACTIONS).
Since the major toxicity is delayed bone marrow suppression, blood counts should be monitored weekly for at least 6 weeks after a dose (see ADVERSE REACTIONS). At the recommended dosage, courses of Gleostine® should not be given more frequently than every 6 weeks.
The bone marrow toxicity of Gleostine® is cumulative and therefore dosage adjustment must be considered on the basis of nadir blood counts from prior dose (see dosage adjustment table under DOSAGE AND ADMINISTRATION)
Medical Affairs:
For product questions or to report suspected adverse events, call 855.672.2468, option 4.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit 
or call 1.800.FDA.1088 (1.800.332.1088).